Manzamine A 是一种口服活性 β-carboline 生物碱,抑制GSK-3β和CDK-5的IC50值为 10.2 μM 和 1.5 μM。Manzamine A 靶向胰腺癌细胞的vacuolar ATPases并抑制自噬 (autophagy)。Manzamine A 具有抗疟和抗癌活性。Manzamine A 对HSV-1具有较强的活性。
生物活性 | Manzamine A, an orally active beta-carboline alkaloid, inhibits specificallyGSK-3βandCDK-5withIC50s of 10.2 μM and 1.5 μM, respectively. Manzamine A targetsvacuolar ATPasesand inhibitsautophagyin pancreaticcancercells. Manzamine A has antimalarial and anticancer activities. Manzamine A also shows potent activity againstHSV-1[1][2][3][4]. |
IC50& Target[1][2][3] | Plasmodium | GSK-3β 10.2 μM (IC50) | CDK5 1.5 μM (IC50) | vacuolar ATPases | Malaria | HSV-1 |
|
体外研究 (In Vitro) | Manzamine A (5-50 μM, 18 h) decreases tau phosphorylation, measured with ELISA[1]. Manzamine A (10 μM) inhibits yeastS. cerevisiaegrowth by 30%[2]. Manzamine A displays a few enlarged vacuoles in yeast[2]. Manzamine A (2.5-10 μM, 24 h) increases acidity in pancreatic cancer cells and non-malignant Vero cells[2]. Manzamine A (1 μM, 24 h) inhibits HSV-1 infection in SIRC cells[4]. Manzamine A shows antimalarial activity with an IC50of 8.0 nM (D6 clone) and 11 nM (W2 clone)[5].
Cell Viability Assay[4] Cell Line: | SIRC cell | Concentration: | 0.1, 0.5, 1, 2, 3, 5, and 10 μM | Incubation Time: | 72 h | Result: | Inhibited SIRC cell viability with an IC50of 5.6 μM. |
|
体内研究 (In Vivo) | Manzamine A (50 and 100 mol/kg, p.o. or i.p.) inhibits the growth of the rodent malaria parasitePlasmodium bergheiin infected mice[6]. Manzamine A (8 mg/kg, i.p., daily for 8 consecutive days) prolongs the survival of SW mice to 20 days[7].
Animal Model: | Plasmodium bergheiin infected mice[6] | Dosage: | 50 or 100 mol/kg | Administration: | Intraperitoneal injection (i.p.) or oral administration (p.o.) | Result: | Inhibited the growth of the rodent malaria parasitePlasmodium berghei. Prolonged the survival of highly parasitaemic mice. |
|
分子量 | |
Formula | |
CAS 号 | |
结构分类 | |
来源 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
溶解性数据 | In Vitro: DMSO : 10 mg/mL(18.22 mM;Need ultrasonic) 配制储备液 1 mM | 1.8223 mL | 9.1115 mL | 18.2229 mL | 5 mM | 0.3645 mL | 1.8223 mL | 3.6446 mL | 10 mM | 0.1822 mL | 0.9111 mL | 1.8223 mL |
|